Physician

Scott M Ravis, M.D.

According to 2025 Medicare claims, Scott Ravis, M.D. (NPI: 1902845720) practices dermatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is KANSAS CITY SKIN AND CANCER CENTER, LLC (NPI: 1669670964; TIN: 260330277) and primary practice location at 66204-2217.

Ravis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,546 traditional Medicare patients, billed 8,614 HCPCS/CPT codes, and received $760,455 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 909 prescription claims across 418 beneficiaries totaling $273,378 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 131 records totaling $2,950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $90,339 to $273,378. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,259	7,229	$635,341
2016	1,382	7,258	$609,666
2017	1,341	7,248	$666,823
2018	1,701	8,296	$779,894
2019	1,906	17,028	$751,321
2020	1,815	24,797	$707,449
2021	1,902	23,057	$819,166
2022	1,614	19,413	$743,054
2023	1,195	13,332	$653,762
2024	1,546	8,614	$760,455

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	794	$90,339
2016	373	825	$109,150
2017	380	833	$134,295
2018	391	882	$189,516
2019	407	952	$146,882
2020	368	959	$217,525
2021	425	963	$295,497
2022	377	942	$308,832
2023	429	1,132	$268,121
2024	418	909	$273,378

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	334	406	$492
11102	Biopsy of related skin growth, first growth	311	400	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	713	1,047	$59
88305	Pathology examination of tissue using a microscope, intermediate complexity	977	1,605	$55
17000	Destruction of precancer skin growth, 1 growth	323	414	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Taltz Autoinjector	Ixekizumab	13	364	$87,664
Dupixent Pen	Dupilumab	15	420	$60,240
Ketoconazole	Ketoconazole	150	5,755	$4,565
Clobetasol Propionate	Clobetasol Propionate	85	3,054	$3,356
Tacrolimus	Tacrolimus	17	525	$3,022

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	131	$2,950	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott M. Ravis, M.D.?

Tedicare shows public-source Medicare data for Scott M. Ravis, M.D. (NPI 1902845720), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott M. Ravis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott M. Ravis, M.D.?

Scott M. Ravis, M.D. is linked to KANSAS CITY SKIN AND CANCER CENTER, LLC (billing NPI 1669670964) in the available physician profile data.

Does Scott M. Ravis, M.D. have Open Payments data?

Scott M. Ravis, M.D. has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.